CXCL1 and dermatitis: Oral propionate decreased mRNA expression of IL-17A, IL-17C, IL-17F, IL-22, IL-6, IL-1β, TNF-α, CXCL1, and CCL20 in imiquimod-induced dermatitis in comparison between NDIS versus NDIP (Figure 12).